Perseus Proteomics Inc. (TYO:4882)
Japan
· Delayed Price · Currency is JPY 446.00
+15.00 (3.48%)
May 16, 2025, 3:30 PM JST
Perseus Proteomics Revenue
Perseus Proteomics had revenue of 23.68M JPY in the quarter ending December 31, 2024, with 12.76% growth. This brings the company's revenue in the last twelve months to 111.39M, up 16.03% year-over-year. In the fiscal year ending March 31, 2024, Perseus Proteomics had annual revenue of 100.00M with 6.38% growth.
Revenue (ttm)
111.39M
Revenue Growth
+16.03%
P/S Ratio
59.06
Revenue / Employee
4.46M
Employees
25
Market Cap
6.58B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |